Our results demonstrated that CC1007 could effectively inhibit the expression of both HDAC7 and MEF2C, and reduced HDAC7 protein aggregation in the nuclei in BCR-ABL1− pre-B-ALL cells. This evidence concerns the gene BCR and acute lymphoblastic leukemia.